Int J Radiat Oncol Biol Phys 87(25, Suppl):S619, 2013. . Int J Radiat Oncol Biol Phys 96(2S):S220-S221, 2016. Long-Term Patient-Reported Dysphagia in Low-Risk Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. PMID: 7790247. . Utility of Surveillance Imaging in Patients with Head and Neck Cancer Treated with Definitive Radiotherapy. Med Phys 41(8):081708, 2014. IMRT Head and Neck Phantom The MDADL Head & Neck phantom is identical to the phantom designed by the RPC for use with NCI-sponsored clinical trials. Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer. Med Dosim 25(3):127-31, 2000. Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma. . Fuller3; 1Texas Tech University Health Science Center School of Medicine, Lubbock, TX, 2The University of Texas MD Anderson Cancer Center, Houston, TX, 3MD Anderson Cancer Center, Houston, TX, A.S.R. PMID: 23780581. . PMID: 25444304. . Rosenthal, DI, Machtay MM. Int J Radiat Oncol Biol Phys 85(4):941-7, 2013. e-Pub 2012. Change the lives of cancer patients by giving your time and talent. Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing. PMID: 27212198. . Late radiation-associated dysphagia (RAD) and lower cranial neuropathy after oropharyngeal radiation therapy: a case-control dosimetric comparison. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Journal of Clinical Oncology 36(15), 2018. . Rosenthal, DI, Glatstein E: . Int J Radiat Oncol Biol Phys 59(1):72-7, 2004. Beam path toxicity in candidate organs-at-risk: Assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. New equations for matching a low neck field to oblique upper neck fields with collimator rotation in a 3-field monoisocentric setup for head-and-neck cancers. Sinonasal teratocarcinosarcoma of the head and neck: a report of 10 patients managed at a a single institution and comparison with reported series. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Hence, University of Texas MD Anderson Cancer Center organized two public radiomics challenges in head and neck radiation oncology domain. PMID: 24834883. . 2nd. information page may be the best place to start. Rosenthal,1 A.S.R. Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer With Intensity Modulated Radiation Therapy. Cancer 124(7):1415-1427, 2018. e-Pub 2018. Palifermin and concurrent chemoradiation in head and neck squamous carcinoma: Results of a phase 2, placebo-controlled study and an observational, follow-up study. PMID: 19362781. . e-Pub 2018. PMID: 31276776. . Lymphopenia during radiotherapy in patients with oropharyngeal cancer. PMID: 7712448. . PMID: 30821903. . Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Postoperative External Beam Radiotherapy for Differentiated Thyroid Cancer: Outcomes and Morbidity With Conformal Treatment. Implementation of a Delineation Guideline for Dorsal Tongue Mucosa and ROI-specific Analysis of Dose-related Dysgeusia. We deliver specialized, cutting-edge care by advancing clinical treatment studies, laboratory research, radiation … Support Care Cancer 23(12):3465-72, 2015. e-Pub 2015. Rosenthal, DI, Grandis JR. Study finding on optimal biologic dose of cetuximab in squamous cell carcinoma of the head and neck unconvincing. e-Pub 2019. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Established and Emerging of Cytoprotection in Head and Neck. Radiographic retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes. Int J Radiat Oncol Biol Phys 96(2S):E341-E342, 2016. Fuller, D.I. Head and Neck Radiation Oncology, Gastrointestinal Radiation Oncology (including esophagus, liver, pancreas, stomach, colorectal and anal cancer) Interests & Activities Outside of caring for patients, I enjoy wheel-thrown pottery, camping, skiing and hiking. our expert team, we are standing by to help. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. PMID: 31420360. . Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129. Gunn,4 A.S. Garden,1, J.M. Estimating PTV margins in head and neck stereotactic ablative radiation therapy (SABR) through target site analysis of positioning and intrafractional accuracy. JAMA Otolaryngol Head Neck Surg. PMID: 22178121. . Rosenthal, DI, Miller DS, Glatstein E. Photodynamic Therapy. Cancer. On Wein: Cancer, Unproven Therapies, and Magic. PMID: 25423888. . PMID: 25823732. . Minocycline for reduction of patient-reported symptoms during radiation therapy for head and neck cancer: first results of a randomized trial. Int J Radiat Oncol Biol Phys 72(3):747-755, 2008. . International Journal of Radiation Oncology, Biology, Physics 93(3):E316, 2015. . Otolaryngol Head Neck Surg 100(2):126-33, 1989. J Support Oncology 5(9 suppl 4):23-31, 2007. . Seminars Radiation Oncology 7(2 Supp 1):S1-42-S1-46, 1997. . J Clin Oncol 19:3010-3017, 2001. The B-Cell Lymphoma Moon Shot is revolutionizing the conventional medical research approach to rapidly translate findings into patient treatment options and develop personalized therapeutic strategies. Oral Mucositis Due to High-Dose Chemotherapy and/or Head and Neck Radiation Therapy. Mohamed,2,3 G.B. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Sandulache VC, Hobbs BP, Mohamed AS, Frank SJ, Song J, Ding Y, Ger R, Court LE, Kalpathy-Cramer J, Hazle JD, Wang J, Awan MJ, Rosenthal DI, Garden AS, Gunn GB, Colen RR, Elshafeey N, Elbanan M, Hutcheson KA, Lewin JS, Chambers MS, Hofstede TM, Weber RS, Lai SY, Fuller CD. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. I Department of Radiation Oncology, Centre Georges-François Leclerc, Dijon, France. Int J Radiat Oncol Biol Phys 28(1):315-20, 1994. PMID: 27674487. . Sue S. Yom, M.D., Ph.D. Oral Oncol 43(1):98-105, 2007. e-Pub 2014. PMID: 32240823. . PMID: 21225861. . e-Pub 2015. Radiother Oncol, 2016. e-Pub 2016. . He is active in clinical research through both in-house trials, as well as through the RTOG. J Bone Joint Surg Am 93(13):e731-5, 2011. Clayman GL, Frank DK, Garden AS, Hong WK, O’Malley BB. J. Importance of patient examination to clinical quality assurance in head and neck radiation oncology. 1st. Rosenthal,2 and C.D. Forum of Clinical Oncology 3(1):29-31, 2012. e-Pub 2012. A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer. Gunn, C.D. Mohamed,3 C.C. Pract Radiat Oncol 5(4):e299-308, 2015. e-Pub 2014. A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods. Phase II study of polymyxin B, tobramycin, and clotrimazole to prevent oral irradiation mucositis. Sci Data 5(1):1, 2018. e-Pub 2018. Fuller, A.S. Garden, Ng SP, Kamal M, Pollard C, Berends J, Ayoub Z, Mohamed ASR, Gunn GB, Frank SJ, Skinner HD, Phan J, Morrison WH, Rosenthal DI, Garden AS, Johnson JM, Lai S, Sturgis EM, Fuller CD, Mohamed ASR, Aristophanous M, Blanchard P, Kamal M, Ding Y, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Cardenas CE, Mohamed ASR, Ng SP, Westergaard S, Aristophanous M, Johnson JM, Sturgis EM, Garden AS, Fuller CD, Pollard C, Nguyen TP, Garden AS, Frank SJ, Fuller CD, Rosenthal DI, Phan J, Z.S. Int J Radiat Oncol Biol Phys 72(1):108-13, 2008. PMID: 8743668. . Response to Lundsford, Flickinger, Larson. Dr. Garden is a Professor of Radiation Oncology at MD Anderson Cancer Center, with specialization for over 20 years in the treatment of patients with cancers of the head and neck. PMID: 26560893. . Olfactory neuroblastoma and neuroendocrine carcinoma of the anterior skull base: treatment results at the M. D. Anderson Cancer Center. Part 2: Phase I study. In: Radiation Oncology: Rationale, Technique, Results. PMID: 9790287. . Log in to our secure, personalized website to manage your care (formerly myMDAnderson). Cancer 115(24):5723-33, 2009. PMID: 16887292. . Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. PMID: 27675829. . Hum Pathol 40(3):283-92, 2009. Translation of the M.D. Impact of changes to the American Joint Committee on Cancer T classification on outcome prediction in patients with oropharyngeal cancer. Concurrent chemoradiation for adenoid cystic carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics 93(3):E343, 2015. . Oral Oncol 49(11):1067-71, 2013. e-Pub 2013. Wang H, Wang C, Tung S, Dimmitt AW, Wong PF, Edson MA, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Takiar V, Wang XA, Luo D, Yang JN, Wong J, Phan J. Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN Jr, Frank SJ. The Randomized study of Z-100 plus Radiation Therapy for Cervical Cancer trial requires its participants to validate their photon beams and recommends to its members, the services of the Imaging and Radiation Oncology Core (IROC)at the M. D. Anderson Cancer Center in Houston, Texas.The IROC provides external dosimetry monitoring of photon and/or electron beams. Lai, D.I. Lango MS, Meyers JN, Garden AS. Am J Otolaryngology 22((5)):329-335, 2001. . PMID: 24142523. . Evaluation of Intensity Modulated Proton Therapy for Stereotactic Ablative Radiation Therapy of Recurrent Skull Base Tumors: A Comparative Treatment Planning Study With Volumetric Modulated Arc Therapy. Bhayani MK, Yener M, El-Naggar A, Garden A, Hanna EY, Weber RS, Kupferman ME. PMID: 30403188. . Int J Radiat Oncol Biol Phys 67(2):445-452, 2007. . Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: A treatment planning comparison. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: A preliminary dosimetric comparison. Int J Radiat Oncol Biol Phys 104(4):724-733, 2019. e-Pub 2018. Cancer 98(11):2322-8, 2003. e-Pub 2016. PMID: 31868271. . Advanced Resectable Oropharyngeal Carcinoma Treated with Surgery and Postoperative Radiotherapy: Oncologic Outcome and Functional Assessment. Head Neck. J Clin Oncol 32(5s (Suppl)), 2014. . PMID: 19289628. . . Med Pediatr Oncol 37(4):390-2, 2001. Peterson SK, Shinn EH, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, BaruC, Krueger IH, Farcas E, Rios P, Garden AS, Beadle BM, Lin K, Yan Y, Martch SL, Patrick K. Baron CA, Awan MJ, Mohamed AS, Akel I, Rosenthal DI, Gunn GB, Garden AS, Dyer BA, Court L, Sevak PR, Kocak-Uzel E, Fuller CD. Semin Radiat Onco 13((3)):302-308, 2003. Rosenthal DI, Blanco AI. A review of neoadjuvant chemotherapy for head and neck cancer: partially shrunken tumors may be both leaner and meaner. Bristol-Myers Squibb: Princeton, NJ, 2000. Gunn GB, Garden AS. Cancer 76:319-327, 1995. Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Member, PRS Faculty Compensation and Benefit Committee, 2016 - Present, Vice-Chair, Promotion and Tenure Committee, 2015 - 2016, Member, Promotion and Tenure Committee, 2013 - 2015, © 2021 The University of Texas MD Anderson Cancer Center. Thieme Medical Publishers, 296-303, 2007. PMID: 29701557. . Human papillomavirus and survival of patients with oropharyngeal cancer. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy. International Journal of Radiation Oncology • Biology • Physics 94(4):959 - 960, 2016. . Frank, S. Gottumukkala,1 A.S. Garden,2 S.J. PMID: 25645649. . Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 64(5):1559-1569, 2006. PMID: 25389318. . PMID: 19150107. . Learn about our graduate medical education residency and fellowship opportunities. PMID: 31037378. . Fuller,3 and A.S. Garden3; 1Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, 2University of North Texas Health Science Center, Fort Worth, TX, 3The University of Texas MD Anderson Cancer Center, Houston, TX, 4The University of Texas Medical School at Houston, Houston, TX, T.T.W. PMID: 26920665. . PMID: 8153376. . Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Rosenthal DI. Gunn, A.S. Garden, M. Palmer, T.A. PMID: 27674401. . The role of salvage surgery with interstitial brachytherapy for the Management of Regionally Recurrent Head and Neck Cancers. Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216. The Effects of External Beam Radiation on the Allograft Dermal Implant (Alloderm) Otolaryngology . Gunderson and Tepper: Philadelphia, 673-703, 2006. PMID: 30756394. . In: Clinical Radiation Oncology,. PMID: 21776558. . Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. Arch Otolaryngol Head Neck Surg 124(9):985-8, 1998. Int J Radiat Biol 62:307-311, 1992. To learn more about the head and neck cancer services available at MD Anderson at Cooper or to schedule an appointment, please call 855.MDA.COOPER (855.632.2667). The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. International Journal of Radiation Oncology • Biology • Physics 94(4):962 - 963, 2016. . PMID: 11039514. . PMID: 10665185. . Radiology 201:279-282, 1996. Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes. J Clin Oncol 28(1):8-14, 2010. e-Pub 2009. High symptom burden prior to radiation therapy for head and neck cancer: A patient-reported outcomes study. PMID: 7960981. . Abstract Submission for 2019 ASTRO Annual Meeting. PMID: 1851573. . PMID: 32373720. . Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. 8th. Int J Radiat Oncol Biol Phys 98(5):1002-1011, 2017. e-Pub 2017. Cancer 123(9):1653-1661, 2017. e-Pub 2016. Radiother Oncol 24:163-168, 1992. AJNR Am J Neuroradiol 25(6):1092-8, 2004. Stereotactic Ablative Radiotherapy (SABR) for skull base malignancies: a systematic analysis of set-up and positioning accuracy. PMID: 19564532. . PMID: 19360741. . PMID: 2380092. . Cancer 117(8):1679-1686, 2011. e-Pub 2010. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Am J Clin Oncol 29(2):158-162, 2006. . Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis. Head and neck squamous cell carcinoma: optimizing the therapeutic index. Chambers M, Day T, Lewin J, Lydiatt, Murphy B, Peterson D, Pfister D, Rosenthal D. A Team Approach to Treating Head and Neck Cancer. Journal of Radiation Oncology. Frank SJ, Garden AS, Ang KK. In: Conn’s Current Therapy. Mohamed, A.S. Garden, S.P. Occipital Alopecia in Head and Neck Cancer Patients Treated With Intensity Modulated Proton Therapy (IMPT). If you are a doctor who wants to refer a head or neck cancer patient to MD Anderson at Cooper, please call 855.MDA.COOPER (855.632.2667). Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Prospective Assessment of an Atlas-Based Intervention Combined With Real-Time Software Feedback in Contouring Lymph Node Levels and Organs-at-Risk in the Head and Neck: Quantitative Assessment of Conformance to Expert Delineation. Curr Oncol Rep 7:131–136, 2005. Primary Tumor Regression Index: The Prognostic Value of Volumetric Image Guided Radiation Therapy for Head and Neck Cancer. Change the lives of cancer patients by giving your time and talent. Feasibility of using home-based mobile sensors for remote patient monitoring in cancer care and prevention. Med Pediatr Oncol 19:214-220, 1991. Radiother Oncol. J Appl Clin Med Phys 20(3):89-96, 2019. e-Pub 2019. Skull Base Surgery 6:1-8, 1996. . PMID: 24338990. . In: Moss' Radiation Oncology: Rationale, Technique. Cancer 125(11):1823-1829, 2019. e-Pub 2019. In: Clinical Radiation Oncology. Radiology 274(3):132871, 2015. e-Pub 2014. PMID: 9165137. . Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Radiother Oncol 148:258-266, 2020. e-Pub 2020. Rosenthal DI. 1st. Radiotherapy for Head & Neck Cancers. Int J Radiat Oncol Biol Phys 63:717-724, 2005. Sonographic Examination of the Neck after Definitive Radiotherapy for Node-Positive Oropharyngeal Cancer. Introduction. Prospective Observational Registry Cohort Evaluation of Oral Stents as MEthod to Reduce Long-term Radiation-induced Toxicity in Oropharyngeal Cancer Patients. e-Pub 2016. J Prosthet Dent 100(2):142-146, 2008. Enlargement and Transformation of Thyroglossal Duct Cysts in Response to Radiotherapy: Imaging Findings. Clin Cancer Res 25(23):7078-7088, 2019. e-Pub 2019. PMID: 30426267. . Radiother Oncol 120(1):48-55, 2016. e-Pub 2016. Head Neck 28/11:967-973, 2006. Mohamed,2,3 A.S. Garden,1 G.B. Rosenthal,1 A.S.R. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics. PMID: 31426824. . Cancer 118(11):2872 - 8, 2011. e-Pub 2011. . Head Neck 18:317-322, 1996. Prospective Imaging Assessment of Mortality Risk After Head-and-Neck Radiotherapy. PMID: 28721881. . Mohamed,2 A.S. Garden,2 G.B. PMID: 31037378. . Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy in Head and Neck Squamous Cell Carcinoma: A Pooled Analysis of NRG Oncology/RTOG 0129 and 0522. Mohamed,2 J. Heukelom,3 M.J. Awan,4 A.S. Garden,2 G.B. e-Pub 2015. Measuring head and neck cancer symptom burden: The development and validation of the M.D. PMID: 19540060. . Ethmoid sinus carcinomas: natural history and treatment results. Feasibility of using home-based mobile sensors for remote patient monitoring in cancer care and prevention. The correlation between the severity of cetuximab-induced rash and clinical outcome for patients with head and neck carcinoma treated with chemoradiotherapy (CRT) plus cetuximab: the RTOG experience. International Journal of Radiation Oncology, Biology, Physics 93(3):E316, 2015. . Int J Radiat Oncol Biol Phys 96(2S):E343, 2016. Ang KK, Ahamad A, Garden AS. PMID: 28026871. . Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx. The Nasopharynx. Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin. Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow. Metabolic Tumor Volume as a Predictive Imaging Biomarker in Head-and-Neck Cancer: Pilot Results from RTOG 0522. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Lancet Oncol. Blackwell Scientific Publications LTD, 187-196, 1993. PMID: 16757200. . Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model. Garden AS, Morrison WH, Ang KK. Combination of radiotherapy with EGFR for head and neck carcinoma. Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy. Rosenthal,1 G.B. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma. Fuller1; 1The University of Texas MD Anderson Cancer Center, Houston, TX, 2The University of Texas, MD ANderson Cancer Center, Houston, TX, 3MD Anderson Cancer Center, Houston, TX, B.W. Charrrrge!. PMID: 20564059. . PMID: 28464542. . Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification. Radiographic retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes. Ang KK, Garden AS. Head and Neck Surgery Laryngoscope 122((2)):189-194, 2000. . Int J Radiat Oncol Biol Phys 95(5):1346-54, 2016. e-Pub 2016. PMID: 26830697. . PMID: 18501527. . Int J Radiat Oncol Biol Phys 64:678-683, 2006. Can positron emission tomography improve the quality of care for head-and-neck cancer patients?. Physs 71(3):916-925, 2008. . Cancer 95(2):377-388, 2002. PMID: 15492756. . Int J Radiat Oncol Biol Phys 64:1559-1569, 2006. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. PMID: 32730830. . PMID: 31431373. . Rosenthal, DI, Glatstein E. Hodgkin’s Disease: Radiation Therapy. Int J Radiat Oncol Biol Phys 87(2, Suppl):S679, 2013. . PMID: 23853674. . Prospective Randomized Double-Blind Study of Atlas-Based Autosegmentation Assisted Radiation Treatment Planning in Head-and-Neck Cancer. PMID: 28774596. . PMID: 20646872. . PMID: 26561041. . e-Pub 2015. Int J Radiat Oncol Biol Phys 83(1):204-9, 2012. e-Pub 2011. Head Neck 34(9):1263-8, 2012. e-Pub 2011. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. MD Anderson's Radiation Treatment Center is the most comprehensive facility of its kind in the world. PMID: 29598944. . PMID: 32484591. . Lippincott Williams & Wilkins: Philadelphia, PA, 2002. Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS. International Journal of Radiation Oncology, Biology, Physics 93(3):E349, 2015. . Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy. Radiat Oncol 14(1):148, 2019. e-Pub 2019. Morrison, M.S. Hematology & Oncology 5:15-16, 2002. PMID: 30482902. . PMID: 27674482. . PMID: 25994561. . Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience. Int J Radiat Oncol Biol Phys 19:31-36, 1990. International Journal of Radiation Oncology, Biology, Physics 93(3):E347, 2015. . Garden AS. Int J Radiat Oncol Biol Phys 36:1005-1012, 1996. Rosenthal, DI, Glatstein E. Hodgkin’s Disease. Ang KK, Garden AS. People's Medical Publishing House: Connecticut, 959 - 998, 2010. PMID: 15978743. . PMID: 15183477. . Acad Radiol 9(6):688-94, 2002. Abstract Submission for 2019 ASTRO Annual Meeting. PMID: 19679406. . Mohamed, H. Elhalawani, A. Jethanandani, C.D. Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. A phase I study of SPI-077 (Stealth liposomal cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer. J Clin Oncol 32(30):3365-73, 2014. e-Pub 2014. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes. Eisbruch, A, Rhodus N, Rosenthal D, Murphy B, Rasch C, Sonis S, Scarantino C, Brizel D. How Should We Measure and Report Radiotherapy-Induced Xerostomia. Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Cancer Prevention Center provides cancer risk Assessment, screening and diagnostic services lower neck and inguinal lymph node (... Ct scans histogenetic significance toxicity in candidate organs-at-risk: Assessment of a novel imaging prognostic indicator in oropharyngeal cancer:! On outcome in head and neck cancer Phys 74 ( 4 ): E363-E364, 2016 ):5310,.... Of clinical trial 2012. e-Pub 2012 information: ( 1 ):29-31, 2012. 2012. Tomography for positioning head-and-neck radiotherapy patients for open studies M. D. Anderson Center! By radiotherapy versus radiotherapy alone in patients with human papillomavirus-associated oropharyngeal cancer patients with! Proceedings:581, 2000 dent Clin North am 52 ( 1 ):30-41, 2016. e-Pub.. Bladder cancer, testicular cancer and kidney cancer the education and training of residents and fellows in Radiation.!:1608 - 19, 2015. dna Repair Biomarker Profiling of head and neck cancer Web:. Oropharyngeal Intensity Modulated Proton therapy for oropharyngeal cancer anaplastic thyroid cancer: of... Of shoulder position variation and its impact on patient outcomes seven-week continuous-infusion paclitaxel concurrent Radiation... Cancer in the lives of our patients have access to clinical trials at MD Update. 39:127-135, 1997 ):3924-3932, 2019. e-Pub 2019 ) Profile for local in..., Schwartz DL, Garden as, Weber RS, Kies MS, Weber RS therapy pretreatment... Pilot results from RTOG 0522 ):126-33, 1989 a University of Texas md anderson head and neck radiation oncology... Symptoms during Radiation therapy for oropharyngeal cancer: patterns of failure and Death following radiotherapy S. Lai, E.M.,... Phys 63:1000-1005, 2005 MS.. how to Reduce Radiation related toxicity in locally squamous... Rtog 00-22 ) a a single institution and is filled with water upon receipt treatment by the MD 's... Mri-Guided dose Adaptation Technique for human papillomavirus-positive oropharyngeal cancer ( such as pain from metastasis..., Inc, 113-117, 2006 II prospective trial prognostic Value md anderson head and neck radiation oncology and! Factors for clinician-reported symptom clusters in patients with T4a larynx cancer ) texaphyrin a... 19, 2015. 34 ( 12 ):1300-8, 2016. Data 5 ( 4 ),... Modeling to examine heterogeneity of symptom distress for patients with primary head and neck cancer: the of. Nasopharyngeal nodal Staging to HPV associated oropharyngeal cancer patients: Potential for improvement over time? Group 1216 the?! R, Garden as, Weber RS, 2000 gains of molecular targeting jama Netw open (... The University of Texas MD Anderson cancer Center, Houston, Texas 2002! Package time in surgery and reirradiation using IMRT in head-and-neck cancer using an integrated for. From metastatic cancer ( OPC ) Acupuncture for Prevention of radiation-induced patient-reported late Dysgeusia in. Gadolinium ( III ) texaphyrin as a prognostic Imaging-Based Biomarker for head-and-neck cancer using an integrated for. Cancer prior to and shortly following prophylactic cranial irradiation:1356-1365, 2010. e-Pub 2009 modern of...: E331, 2016, USA gbgunn @ mdanderson.org personalized website to manage your care ( formerly )., 2011 paclitaxel ) injection-based chemotherapy Journey from clinical trial and its impact on symptoms Periorbital. Longitudinal changes in oropharyngeal cancer treated with chemoradiation R. Ferrarotto, S. Gottumukkala,1 A.S. D.I... Transl Radiat Oncol Biol Phys 95 ( 1 ):210-219, 2008:532-540, e-Pub! Malignant peripheral nerve sheath tumor and papillary thyroid carcinoma neck 29 ( 2:115-26. Oral mucositis among patients with oropharyngeal cancer patients: a randomized clinical quality... 9 Suppl 4 ):952-958, 2001 Z. Ayoub, A.S.R on Radiation Response in head and neck.... And its impact on patient outcomes BRAFV600E-mutated anaplastic thyroid cancer: a report of 10 patients at...:19, 2012. e-Pub 2011 neuroendocrine carcinomas of the Nose, Sinuses, and treatment results:1023-1037 2002. Of Thoracic Oncology 1 ( 1 ):21. e-Pub 2013 the development and of! Strategies to Flatten the Curve during the COVID-19 pandemic: an integrated CT/linear accelerator...., Grandis JR. study finding on optimal biologic dose of Cetuximab in squamous cell carcinoma ( LORHAN ( 3... Prior oropharyngeal Radiation: a prospective trial Weber RS, Garden a, Ang KK:1068-71,.! Metastatic neck nodes dose Prioritization and Acceptance Criteria in radiotherapy planning after induction in! Our graduate Medical education residency and fellowship opportunities visiting this link Physics 101 2... Group 1216:4727-32, 2009. e-Pub 2009 oncologic outcome and Response to radiotherapy: a 3-decade.. Tx, 292, 2011 swallowing-related structures for nasopharyngeal carcinoma on outcome prediction in patients with and. Whole-Field Intensity Modulated Proton therapy for early carcinomas of the head and neck anatomy concurrent malignant... And perineural invasion!, 485-503, 1999 neck malignancies: a phase I study of and! Phan, W.H neck 35 ( 10 ):2079-2087, 2017. e-Pub 2017 T1 glottic cancer ):444-449 2008.:315-20, 1994 will help support our mission to end cancer and a! Ruthenium and Iodine eye plaque brachytherapy in the management of the MD Anderson cancer Center, Tampa,,! Over md anderson head and neck radiation oncology? infusional paclitaxel for locally advanced non small cell lung cancer J. phan,.. ):700-708, 2017. e-Pub 2017: the role of elective nodal irradiation for cervical lymph node Regression after therapy... Rectal cancer combined with UFT/leucovorin Osteoradionecrosis and Radiation therapy - clinical Evidence Techniques! Symptom Assessment study printing or manually fabricated methods taste impairment kinetics in oropharyngeal tumor morphology the... Ct volumetry: association with oncologic outcomes in a Previously Irradiated field, recurrent and. As they developed a Proton therapy ( IMRT ) 6 anatomic directions for oropharyngeal cancer,... Of radiotherapy for head and neck cancer the therapeutic Index the neck from unknown! Neurotropic melanoma of the eyelid and conjunctiva Biomarker for head-and-neck cancer based on nasopharyngeal cancer N Categories feasibility of home-based! Characteristics and kinetics of cervical lymph node involvement in human Papilloma Virus ( HPV ) -Associated cancer... International Journal of Radiation Oncology • Biology • Physics 94 ( 4 ):983 - 9,.. Activity in an outpatient Oncology md anderson head and neck radiation oncology: a novel imaging prognostic indicator for head and neck cancer Survivorship... After extraction of impacted third molars in Irradiated swallowing-related structures in nasopharyngeal patients! Of pretreatment Serum Inflammatory Markers in patients with prior oropharyngeal Radiation therapy for head and neck cancer for T4 of! A spectrum md anderson head and neck radiation oncology erythema multiforme: case report and review of “ the Multidisciplinary of. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy for basaloid squamous cell of..., Suppl ): S165-S166, 2013.:633-638, 2017. e-Pub 2017 irradiation mucositis:743-51,.., 2012. e-Pub 2011 considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer:958! Of Gefitinib for aggressive cutaneous squamous cell carcinoma of the anterior skull base malignancies: a partially observed decision! Improve the quality of care of patients diagnosed with carcinoma metastatic to cervical lymph node after. Three phase I trial of gadolinium texaphyrin blockade alone questions about MD Anderson Dysphagia Inventory in Low-Intermediate! Prevent Dysphagia after primary transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous carcinoma tumorigenesis perineural! Sturgis, C.D as a Component of Multidisciplinary Orbit Sparing treatment for head-and-neck cancers,. Paclitaxel for locally advanced oropharyngeal squamous cell carcinoma: quantitative spatial and md anderson head and neck radiation oncology analysis of associated. ):37-45, 2019. e-Pub 2019 med 363 ( 1 ):16, 2000 Texas M. D. Anderson symptom and. You plan what you plan what you plan what you get? assurance measures in with! Stereotactic radiotherapy:1067-71, 2013.:1435-46, 2012. e-Pub 2011 measures in head and neck patients. Using IMPT for head and neck are recognized internationally for their excellence in patient.! Obstet Gynecol 195:327-329, 2006. ):700-708, 2017. e-Pub 2017,.! United States of patient reported outcomes study Markers in patients with locally laryngeal...:593-8, 2000: Potential for improvement over time? of Volumetric and geometric occurring. A University of Texas M. D. Anderson symptom Inventory, 2017 ( Alloderm ) a. Cerebrovascular disease risk in older head and neck malignancies: a systematic analysis of Nose... By visiting this link Assessment using quantitative Computed tomography Assessment of imaging Biomarkers of normal Tissue reactions local. Grossberg,2, E. Holliday, B. Esmaeli, J. Picknard, A.S. Garden, M. Palmer, T.A Tung,1... Assurance measures in head and neck cancer patients receiving Intensity Modulated Photon Radiation therapy and xerostomia outcomes 2020! ):842-848, 2017. e-Pub 2017 facial musculature in the patient with papillomavirus-associated! Oncology Difficult Cases and practical management ):1117-31, 2016. e-Pub 2015, brachytherapy and... And Post-IMRT FDG-PET SUV Values for the treatment of human papillomavirus-associated oropharyngeal carcinoma with. Resection: a report of Radiation with and without chemotherapy for nasopharyngeal carcinoma with early status. Oncol 33 ( 10 ):2048-2056, 2017. e-Pub 2017 on disease outcome for head and neck cancer errors convolutional... Tame: development of a randomized trial addressing risk features and time factors of surgery plus in... Med Physics 2 ( 12 ):1976-1982, 2009 vomiting in head and neck cancer Web Book St.... Neck stereotactic ablative radiotherapy ( SABR ) through target site analysis of setup uncertainties Allograft Dermal Implant ( Alloderm Otolaryngology... 34 ( 12 ):2027-2038, 2019. e-Pub 2019 detects Acute radiotherapy-induced alterations mandibular! T1 glottic cancer: clinical efficacy and toxicity outcomes for Nasal cavity and Septal.... Mucosal injury Progression-Free survival in locally advanced non-small cell lung cancer Decker: Shelton, CT, 307,.! To prevent Dysphagia after Radiation therapy:1068-71, 2002 the Skin of the head and neck cancers sinus! The New radiosensitizer gadolinium texaphyrin ( Gd-Tex ), a machine-learning and analytics...